Status:
COMPLETED
Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin.
Lead Sponsor:
Technische Universität Dresden
Conditions:
Healthy Subjects
Eligibility:
MALE
18-45 years
Phase:
NA
Brief Summary
Vascular responses to angiotensin II and histamine are compared before and after 30 days of systemic treatment with either irbesartan 150 mg or atorvastatin 20 mg.
Detailed Description
Vascular responses to angiotensin II and histamine are compared before and after 30 days of systemic treatment with either irbesartan 150 mg or atorvastatin 20 mg.
Eligibility Criteria
Inclusion
- healthy subjects
- no relevant disease
- amendment: hypercholesterolaemic subjects
Exclusion
- any relevant disease
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
End Date :
October 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00154024
Start Date
March 1 2003
End Date
October 1 2006
Last Update
September 28 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Clinical Pharmacology, Medical Faculty, University of Technology
Dresden, Germany, 01307